5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects.

Persons with a thermolabile form of the enzyme 5,10 methylenetetrahydrofolate reductase (MTHFR) have reduced enzyme activity and increased plasma homocysteine which can be lowered by supplemental folic acid. Thermolability of the enzyme has recently been shown to be caused by a common mutation (677C-->T) in the MTHFR gene. We studied 41 fibroblast cultures from NTD-affected fetuses and compared their genotypes with those of 109 blood specimens from individuals in the general population. 677C-->T homozygosity was associated with a 7.2 fold increased risk for NTDs (95% confidence interval: 1.8-30.3; p value: 0.001). These preliminary data suggest that the 677C-->T polymorphism of the MTHFR gene is a risk factor for spina bifida and anencephaly that may provide a partial biologic explanation for why folic acid prevents these types of NTD.

[1]  M. Norusis,et al.  Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. , 1991, American journal of human genetics.

[2]  R. Matthews,et al.  Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification , 1994, Nature Genetics.

[3]  S. S. Kang,et al.  Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. , 1988, American journal of human genetics.

[4]  P. Mastroiacovo,et al.  Spina bifida, 677T→C mutation, and role of folate , 1995, The Lancet.

[5]  D C Shields,et al.  A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. , 1995, QJM : monthly journal of the Association of Physicians.

[6]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.

[7]  M. den Heyer,et al.  Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida , 1995, The Lancet.

[8]  H. Blom,et al.  Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? , 1994, Metabolism: clinical and experimental.

[9]  C. Ou,et al.  Is mutated MTHFR a risk factor for neural tube defects? , 1996, The Lancet.

[10]  I. Rosenberg,et al.  Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. , 1996, Circulation.

[11]  H. Blom,et al.  Neural tube defects and elevated homocysteine levels in amniotic fluid. , 1995, American journal of obstetrics and gynecology.

[12]  J. Mills,et al.  Homocysteine metabolism in pregnancies complicated by neural-tube defects , 1995, The Lancet.